Long-term survival and cure fraction estimates for paediatric central nervous system tumours in 31 European countries (EUROCARE-6): a population-based study
Raoull Hoogendijk, Mariëtte E.G. Kranendonk(Princess Máxima Center), Eelco W. Hoving(Princess Máxima Center), Henrike E. Karim‐Kos(Erasmus University Rotterdam), Otto Visser(Netherlands Comprehensive Cancer Organisation), Pieter Wesseling(Radboud University Nijmegen), Jasper van der Lugt(Princess Máxima Center), Riccardo Capocaccia(Departamento de Epidemiología), Gemma Gatta(Fondazione IRCCS Istituto Nazionale dei Tumori), Dannis G van Vuurden(Cancer Center Amsterdam)
Cited by 5
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
<scp>WHO</scp> 2016 Classification of gliomas
|Neuropathology and Applied Neurobiology|2017|817
Diffuse glioma growth: a guerilla war
|Acta Neuropathologica|2007|640
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
|Annals of Oncology|2021|577
Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells
|Proceedings of the National Academy of Sciences|2010|532